Modulators of insulin action and their role in insulin resistance.
Insulin is a key anabolic hormone that plays a crucial role in growth, differentiation and metabolism. Insulin action is initiated by the binding of the hormone to its tyrosine kinase cell surface receptor, leading to the multisite autophosphorylation of the receptor. This results in the activation of the receptor kinase and subsequent tyrosine phosphorylation of insulin receptor substrates, most of which are docking proteins for signaling molecules. For the last several years, our laboratory has been interested in the mechanisms that lead to the modulation of insulin signal transduction, and hence might be involved in insulin resistance found in obesity and type II diabetes. For this review, we have focused on three 'modulators' of insulin action: hyperinsulinemia, suppressor of cytokine signaling proteins and advanced glycation end products.
Pirola
L
L
INSERM Unit 145, Faculty of Medicine, Nice, France.
Johnston
A M
AM
Van Obberghen
E
E
D016207:Cytokines / Q000502:physiology; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology; D017127:Glycation End Products, Advanced / Q000502:physiology; D006801:Humans; D006946:Hyperinsulinism / Q000503:physiopathology*; D007328:Insulin / Q000502:physiology*; D007333:Insulin Resistance; D015398:Signal Transduction
D016207:Cytokines; D017127:Glycation End Products, Advanced; D007328:Insulin